Healthcare Update

Hey all! Hope spring break was nice. Just wanted to update you on Biogen and a potential buy in the coming weeks...

Biogen at 11 AM today was at 44.40 down from what it opened at 44.45. While this stock was upgraded from a hold to a buy on March 6, 2007, according to reports by thestreet.com it is believed that Biogen's performance will continue to decline:

Biotech firm Biogen (BIIB - Cramer's Take - Stockpickr - Rating) has been downgraded to a hold from a buy. The company has developed drugs for the treatment of non-Hodgkin's lymphoma, multiple sclerosis and rheumatoid arthritis. The company has demonstrated earnings-per-share growth over the past two years, but that hasn't pushed up the price of the stock. The stock price has actually fallen 7.7% over the past year. TheStreet.com Ratings doesn't see anything in the company's numbers that would change the trend. Biogen had been rated a buy since November 2006.

Other picks I have been considering include...

Biovail (BVF): a specialty pharmaceutical company, engages in the formulation, clinical testing, registration, manufacture, and commercialization of pharmaceutical products utilizing oral drug-delivery technologies.

Bayer AG (BAY): Bayer AG offers pharmaceuticals and health care products, agricultural products, and polymers. It operates in three groups: HealthCare, CropScience, and MaterialScience.

**For more info go to Yahoo! Finance**

Post opinions/email/discuss tonight...